Anyhow, in Canada there are ways of having access to experimental drugs.
Suppose someone has HIV and all the drugs he has taken up to now are not working anymore. If a new drug arrives on the market and is promising, even though it may also have undesirable effects, that we do not know everything about, if the person, who is in the terminal phase or about to die, wants to try it out, I do not think we can stand in his way.
The same is true for someone, for instance, who is in the terminal phase of cancer. We are talking here about very serious cases. We are not talking about problems like arthritis, for which drugs that have already been proven are on the market. You can market a new product, whose undesirable effects you are not aware of, when there are drugs that have already been proven.
Dr. Graham of the Food and Drug Administration, the FDA, said though that the first thing he learned at medical school was never to be the first to test a new drug. When a disease is not life-threatening—In my case, I would not be the first to try out a new drug. In other circumstances, however, it may be different.